Characterization of chemically defined poly-N-isopropylacrylamide based copolymeric adjuvants.

[1]  Francisco M Gama,et al.  Polymeric nanogels as vaccine delivery systems. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[2]  A. Shakya,et al.  Boronate affinity chromatography of cells and biomacromolecules using cryogel matrices. , 2012, Enzyme and microbial technology.

[3]  Akhilesh Kumar Shakya,et al.  Adjuvant properties of a biocompatible thermo-responsive polymer of N-isopropylacrylamide in autoimmunity and arthritis , 2011, Journal of The Royal Society Interface.

[4]  Kutty Selva Nandakumar,et al.  Collagen type II and a thermo-responsive polymer of N-isopropylacrylamide induce arthritis independent of Toll-like receptors: a strong influence by major histocompatibility complex class II and Ncf1 genes. , 2011, The American journal of pathology.

[5]  Poonam Sharma,et al.  Synthesis and characterization of thermo-responsive poly(N-isopropylacrylamide)-bovine liver catalase bioconjugate , 2010 .

[6]  Heather E Canavan,et al.  Biological cell detachment from poly(N-isopropyl acrylamide) and its applications. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[7]  B. Narasimhan,et al.  Vaccine adjuvants: current challenges and future approaches. , 2009, Journal of pharmaceutical sciences.

[8]  Kutty Selva Nandakumar,et al.  Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis , 2009, The Journal of experimental medicine.

[9]  B. Mattiasson,et al.  Smart polymers: Physical forms and bioengineering applications , 2007 .

[10]  A. Tuncel,et al.  A new thermosensitive fluorescent probe for diol sensing: Poly(N-isopropylacrylamide-co-vinylphenylboronic acid)-alizarin red S complex , 2007 .

[11]  B. Mattiasson,et al.  Interaction of sugars, polysaccharides and cells with boronate‐containing copolymers: from solution to polymer brushes , 2006, Journal of molecular recognition : JMR.

[12]  D. Kimpel,et al.  Animal models of rheumatoid arthritis and their relevance to human disease. , 2005, Pathophysiology : the official journal of the International Society for Pathophysiology.

[13]  Kutty Selva Nandakumar,et al.  Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type II collagen , 2005, Arthritis research & therapy.

[14]  O. Johnell,et al.  The major T cell epitope on type II collagen is glycosylated in normal cartilage but modified by arthritis in both rats and humans , 2005, European journal of immunology.

[15]  R. Holmdahl,et al.  Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  G. Firestein.  Evolving concepts of rheumatoid arthritis , 2003, Nature.

[17]  R. Holmdahl,et al.  Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen‐induced arthritis , 2002, European journal of immunology.

[18]  Anna Gutowska,et al.  Lessons from nature: stimuli-responsive polymers and their biomedical applications. , 2002, Trends in biotechnology.

[19]  R. Edelman.  The development and use of vaccine adjuvants , 2002, Molecular biotechnology.

[20]  B Mattiasson,et al.  Type-specific separation of animal cells in aqueous two-phase systems using antibody conjugates with temperature-sensitive polymers. , 2001, Biotechnology and bioengineering.

[21]  B Mattiasson,et al.  'Smart' polymers and what they could do in biotechnology and medicine. , 1999, Trends in biotechnology.

[22]  R. Holmdahl,et al.  B cell‐deficient mice do not develop type II collagen‐induced arthritis (CIA) , 1998, Clinical and experimental immunology.

[23]  G. Fields,et al.  Promotion of Fibroblast Adhesion by Triple-helical Peptide Models of Type I Collagen-derived Sequences (*) , 1996, The Journal of Biological Chemistry.

[24]  R. Holmdahl,et al.  T cell recognition of carbohydrates on type II collagen , 1994, The Journal of experimental medicine.

[25]  R. Holmdahl,et al.  Variable region gene selection of immunoglobulin G‐expressing B cells with specificity for a defined epitope on type II collagen , 1993, European journal of immunology.

[26]  R. Holmdahl,et al.  Collagen induced arthritis as an experimental model for rheumatoid arthritis , 1989, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[27]  L. Klareskog,et al.  Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. , 1986, Arthritis and rheumatism.

[28]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[29]  S. Bertholet,et al.  New horizons in adjuvants for vaccine development. , 2009, Trends in immunology.

[30]  Kutty Selva Nandakumar,et al.  Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammation. , 2008, Arthritis & Rheumatism.

[31]  C. Benoist,et al.  The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease. , 2004, Advances in immunology.

[32]  Kenneth W. Adolph,et al.  Human genome methods , 1998 .